Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) ve...

Por Anne K. Ellis, Margarita Murrieta-Aguttes, Sandy Furey, Christopher Carlsten
Publicado em 2020-08-01

Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride

Por Ignacio J. Ansotegui, Jonathan A. Bernstein, Giorgio W. Canonica, Sandra N. Gonzalez-Diaz, Bryan L. Martin, Mario Morais-Almeida, Margarita Murrieta-Aguttes, Mario Sanchez Borges
Publicado em 2022-05-01